BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 33586390)

  • 1. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
    Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J
    J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors].
    Voytko MS; Klimontov VV; Pospelova TI; Shebunyaeva YY; Fazullina ON
    Probl Endokrinol (Mosk); 2023 May; 69(2):16-23. PubMed ID: 37448267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrine late-effects and bone mineral density after combined treatment of malignant brain tumors in childhood and adolescence].
    Golounina OO; Pavlova MG; Belaya ZE; Kim EI; Glinkina IV; Morgunova TB; Mazerkina NA; Zheludkova OG; Fadeev VV
    Probl Endokrinol (Mosk); 2021 Jan; 67(1):31-40. PubMed ID: 33586390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors.
    Isaksson S; Bogefors K; Åkesson K; Øra I; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
    Osteoporos Int; 2020 Jul; 31(7):1261-1272. PubMed ID: 32008156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density in post-pubertal adolescent survivors of childhood brain tumors.
    Cohen LE; Gordon JH; Popovsky EY; Sainath NN; Feldman HA; Kieran MW; Gordon CM
    Pediatr Blood Cancer; 2012 Jun; 58(6):959-63. PubMed ID: 22431246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
    Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
    Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GH/IGF axis on bone and cartilage.
    Dixit M; Poudel SB; Yakar S
    Mol Cell Endocrinol; 2021 Jan; 519():111052. PubMed ID: 33068640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological basis of bone strength: anatomy, physiology and measurement.
    Hart NH; Newton RU; Tan J; Rantalainen T; Chivers P; Siafarikas A; Nimphius S
    J Musculoskelet Neuronal Interact; 2020 Sep; 20(3):347-371. PubMed ID: 32877972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary Perspectives on the Developing Skeleton and Implications for Lifelong Health.
    Kralick AE; Zemel BS
    Front Endocrinol (Lausanne); 2020; 11():99. PubMed ID: 32194504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma in the age of molecular subgroups: a review.
    Juraschka K; Taylor MD
    J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy.
    Rodari G; Cattoni A; Albanese A
    J Endocrinol Invest; 2020 Feb; 43(2):209-217. PubMed ID: 31452114
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.